-
1
-
-
0025078156
-
Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamione-treated rats
-
Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamione-treated rats. Brain Res 1990, 525:36-44.
-
(1990)
Brain Res
, vol.525
, pp. 36-44
-
-
Abercrombie, E.D.1
Bonatz, A.E.2
Zigmond, M.J.3
-
2
-
-
0027236406
-
Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates
-
Albanese A., Granata R., Gregori B., Piccardi M.P., Colosimo C., Tonali P. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates. Neuroscience 1993, 55:823-832.
-
(1993)
Neuroscience
, vol.55
, pp. 823-832
-
-
Albanese, A.1
Granata, R.2
Gregori, B.3
Piccardi, M.P.4
Colosimo, C.5
Tonali, P.6
-
3
-
-
0033405974
-
Nocturnal sleep structure and temperature slope in MPTP treated monkeys
-
Almirall H., Pigarev I., de la Calzada M.D., Pigareva M., Herrero M.T., Sagales T. Nocturnal sleep structure and temperature slope in MPTP treated monkeys. J Neural Transm 1999, 106:1125-1134.
-
(1999)
J Neural Transm
, vol.106
, pp. 1125-1134
-
-
Almirall, H.1
Pigarev, I.2
de la Calzada, M.D.3
Pigareva, M.4
Herrero, M.T.5
Sagales, T.6
-
4
-
-
0024495170
-
Preservation of dopamine release in the denervated striatum
-
Altar C.A., Marien M.R. Preservation of dopamine release in the denervated striatum. Neurosci Lett 1989, 96:329-334.
-
(1989)
Neurosci Lett
, vol.96
, pp. 329-334
-
-
Altar, C.A.1
Marien, M.R.2
-
5
-
-
0042032778
-
Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: Stable therapeutic effects and wearing-off dyskinesia
-
Andringa G., Stoof J.C., Cools A.R. Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: Stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology (Berl) 1999, 146:328-334.
-
(1999)
Psychopharmacology (Berl)
, vol.146
, pp. 328-334
-
-
Andringa, G.1
Stoof, J.C.2
Cools, A.R.3
-
6
-
-
0026634005
-
Behavioral analysis of unilateral monoamine depletion in the marmoset
-
Annett L.E., Rogers D.C., Hernandez T.D., Dunnett S.B. Behavioral analysis of unilateral monoamine depletion in the marmoset. Brain 1992, 115:825-856.
-
(1992)
Brain
, vol.115
, pp. 825-856
-
-
Annett, L.E.1
Rogers, D.C.2
Hernandez, T.D.3
Dunnett, S.B.4
-
7
-
-
0022589131
-
Hemiparkinsonism in monkeys after unilateral internal carotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Bankiewicz K.S., Oldfield E.H., Chiueh C.C., Doppman J.L., Jacobowitz D.M., Kopin I.J. Hemiparkinsonism in monkeys after unilateral internal carotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 1986, 39:7-16.
-
(1986)
Life Sci
, vol.39
, pp. 7-16
-
-
Bankiewicz, K.S.1
Oldfield, E.H.2
Chiueh, C.C.3
Doppman, J.L.4
Jacobowitz, D.M.5
Kopin, I.J.6
-
8
-
-
33746834485
-
The proteasomal inhibition model of Parkinson's disease: "Boon or bust "?
-
Beal F., Lang A. The proteasomal inhibition model of Parkinson's disease: "Boon or bust"?. Ann Neurol 2006, 60:158-161.
-
(2006)
Ann Neurol
, vol.60
, pp. 158-161
-
-
Beal, F.1
Lang, A.2
-
9
-
-
0026607313
-
Levodopa-induced dyskinesia: Facts and fancy. What does the MPTP monkey model tell us?
-
Bedard P.J., Mancilla B.G., Blanchette P., Gagnon C., Di Paolo T. Levodopa-induced dyskinesia: Facts and fancy. What does the MPTP monkey model tell us?. Can J Neurol Sci 1992, 19:134-137.
-
(1992)
Can J Neurol Sci
, vol.19
, pp. 134-137
-
-
Bedard, P.J.1
Mancilla, B.G.2
Blanchette, P.3
Gagnon, C.4
Di Paolo, T.5
-
10
-
-
0033977075
-
GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation
-
Betarbet R., Porter R.H., Greenamyre J.T. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. J Neurochem 2000, 74:1166-1174.
-
(2000)
J Neurochem
, vol.74
, pp. 1166-1174
-
-
Betarbet, R.1
Porter, R.H.2
Greenamyre, J.T.3
-
11
-
-
1842664191
-
Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease
-
Betarbet R., Poisik O., Sherer T.B., Greenamyre J.T. Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. Exp Neurol 2004, 187:76-85.
-
(2004)
Exp Neurol
, vol.187
, pp. 76-85
-
-
Betarbet, R.1
Poisik, O.2
Sherer, T.B.3
Greenamyre, J.T.4
-
12
-
-
0031960890
-
Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach
-
Bezard E., Gross C. Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach. Prog Neurobiol 1998, 55:96-116.
-
(1998)
Prog Neurobiol
, vol.55
, pp. 96-116
-
-
Bezard, E.1
Gross, C.2
-
13
-
-
0030984413
-
A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey
-
Bezard E., Imbert C., Deloire X., Bioulac B., Gross C.E. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey. Brain Res 1997, 766:107-112.
-
(1997)
Brain Res
, vol.766
, pp. 107-112
-
-
Bezard, E.1
Imbert, C.2
Deloire, X.3
Bioulac, B.4
Gross, C.E.5
-
14
-
-
0034571915
-
Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice
-
Bezard E., Dovero S., Imbert C., Boraud T., Gross C.E. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse 2000, 38:363-368.
-
(2000)
Synapse
, vol.38
, pp. 363-368
-
-
Bezard, E.1
Dovero, S.2
Imbert, C.3
Boraud, T.4
Gross, C.E.5
-
15
-
-
0035434121
-
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies
-
Bezard E., Brotchie J.M., Gross C.E. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001, 2:577-588.
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 577-588
-
-
Bezard, E.1
Brotchie, J.M.2
Gross, C.E.3
-
16
-
-
2942517754
-
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms
-
Blanchet P.J., Calon F., Morissette M., Tahar A.H., Belanger N., Samadi P., Grondin R., Gregoire L., Meltzer L., Paolo T.D., Bedard P.J. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism Relat Disord 2004, 10:297-304.
-
(2004)
Parkinsonism Relat Disord
, vol.10
, pp. 297-304
-
-
Blanchet, P.J.1
Calon, F.2
Morissette, M.3
Tahar, A.H.4
Belanger, N.5
Samadi, P.6
Grondin, R.7
Gregoire, L.8
Meltzer, L.9
Paolo, T.D.10
Bedard, P.J.11
-
17
-
-
0842277727
-
Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach
-
Blandini F. Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach. Exp Neurol 2003, 184:556-560.
-
(2003)
Exp Neurol
, vol.184
, pp. 556-560
-
-
Blandini, F.1
-
18
-
-
33645235438
-
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases
-
Bodner R.A., Outeiro T.F., Altmann S., Maxwell M.M., Cho S.H., Hyman B.T., McLean P.J., Young A.B., Housman D.E., Kazantsev A.G. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci USA 2006, 103:4246-4251.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 4246-4251
-
-
Bodner, R.A.1
Outeiro, T.F.2
Altmann, S.3
Maxwell, M.M.4
Cho, S.H.5
Hyman, B.T.6
McLean, P.J.7
Young, A.B.8
Housman, D.E.9
Kazantsev, A.G.10
-
19
-
-
33846203285
-
Dopamine and adult neurogenesis
-
Borta A., Hoglinger G.U. Dopamine and adult neurogenesis. J Neurochem 2007, 100:587-595.
-
(2007)
J Neurochem
, vol.100
, pp. 587-595
-
-
Borta, A.1
Hoglinger, G.U.2
-
20
-
-
33746850545
-
Proteasome inhibition and Parkinson's disease modeling
-
Bove J., Zhou C., Jackson-Lewis V., Taylor J., Chu Y., Rideout H.J., Wu D.C., Kordower J.H., Petrucelli L., Przedborski S. Proteasome inhibition and Parkinson's disease modeling. Ann Neurol 2006, 60:260-264.
-
(2006)
Ann Neurol
, vol.60
, pp. 260-264
-
-
Bove, J.1
Zhou, C.2
Jackson-Lewis, V.3
Taylor, J.4
Chu, Y.5
Rideout, H.J.6
Wu, D.C.7
Kordower, J.H.8
Petrucelli, L.9
Przedborski, S.10
-
21
-
-
26444532429
-
Nondopaminergic mechanisms in levodopa-induced dyskinesia
-
Brotchie J.M. Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Disord 2005, 20:919-931.
-
(2005)
Mov Disord
, vol.20
, pp. 919-931
-
-
Brotchie, J.M.1
-
22
-
-
0032736127
-
Quantitative assessment of dyskinesia in subhuman primates
-
Brotchie J.M., Fox S.H. Quantitative assessment of dyskinesia in subhuman primates. Mov Disord 1999, 14:40-47.
-
(1999)
Mov Disord
, vol.14
, pp. 40-47
-
-
Brotchie, J.M.1
Fox, S.H.2
-
23
-
-
0001496694
-
A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550.
-
(1983)
Proc Natl Acad Sci USA
, vol.80
, pp. 4546-4550
-
-
Burns, R.S.1
Chiueh, C.C.2
Markey, S.P.3
Ebert, M.H.4
Jacobowitz, D.M.5
Kopin, I.J.6
-
24
-
-
0026526276
-
Long-term synaptic depression in the striatum: Physiological and pharmacological characterization
-
Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: Physiological and pharmacological characterization. J Neurosci 1992, 12:424-4233.
-
(1992)
J Neurosci
, vol.12
, pp. 424-4233
-
-
Calabresi, P.1
Maj, R.2
Pisani, A.3
Mercuri, N.B.4
Bernardi, G.5
-
26
-
-
0029076807
-
Levodopa or D2 agonists induce dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABA A receptors in the striatopallidal complex
-
Calon F., Goulet M., Blanchet P.J., Martel J.C., Piercey F., Bedard P.J., Di Paolo T. Levodopa or D2 agonists induce dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABA A receptors in the striatopallidal complex. Brain Res 1995, 680:43-52.
-
(1995)
Brain Res
, vol.680
, pp. 43-52
-
-
Calon, F.1
Goulet, M.2
Blanchet, P.J.3
Martel, J.C.4
Piercey, F.5
Bedard, P.J.6
Di Paolo, T.7
-
27
-
-
0036139613
-
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
-
Calon F., Morissette M., Ghribi O., Goulet M., Grondin R., Blanchet P.J., Bedard P.J., Di Paolo T. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Prog Neuropsychopharmacol Biol Psychiatr 2002, 26:127-138.
-
(2002)
Prog Neuropsychopharmacol Biol Psychiatr
, vol.26
, pp. 127-138
-
-
Calon, F.1
Morissette, M.2
Ghribi, O.3
Goulet, M.4
Grondin, R.5
Blanchet, P.J.6
Bedard, P.J.7
Di Paolo, T.8
-
28
-
-
0025443256
-
Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size
-
Castaneda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size. J Neurosci 1990, 10:1847-1854.
-
(1990)
J Neurosci
, vol.10
, pp. 1847-1854
-
-
Castaneda, E.1
Whishaw, I.Q.2
Robinson, T.E.3
-
29
-
-
0033398532
-
Unilateral dopamine denervation blocks corticostriatal LTP
-
Centonze D., Gubellini P., Picconi B., Calabresi P., Giacomini P., Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol 1999, 82:3575-3579.
-
(1999)
J Neurophysiol
, vol.82
, pp. 3575-3579
-
-
Centonze, D.1
Gubellini, P.2
Picconi, B.3
Calabresi, P.4
Giacomini, P.5
Bernardi, G.6
-
30
-
-
0035060448
-
Dopaminergic control of synaptic plasticity in the dorsal striatum
-
Centonze D., Picconi B., Gubellini P., Bernardi G., Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 2001, 13:1071-1077.
-
(2001)
Eur J Neurosci
, vol.13
, pp. 1071-1077
-
-
Centonze, D.1
Picconi, B.2
Gubellini, P.3
Bernardi, G.4
Calabresi, P.5
-
31
-
-
0035888924
-
Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP
-
Chassain C., Eschalier A., Durif F. Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP. J Neurosci Method 2001, 111:9-16.
-
(2001)
J Neurosci Method
, vol.111
, pp. 9-16
-
-
Chassain, C.1
Eschalier, A.2
Durif, F.3
-
32
-
-
84882465391
-
Estimation of D2-like Receptor Occupancy by Dopamine in the Putamen of Hemiparkinsonian Monkeys
-
Chefer S.I., Kimes A.S., Matochik J.A., Horti A.G., Kurian V., Shumway D., Domino E.F., London E.D., Mukhin A.G. Estimation of D2-like Receptor Occupancy by Dopamine in the Putamen of Hemiparkinsonian Monkeys. Neuropsychopharmacology 2007.
-
(2007)
Neuropsychopharmacology
-
-
Chefer, S.I.1
Kimes, A.S.2
Matochik, J.A.3
Horti, A.G.4
Kurian, V.5
Shumway, D.6
Domino, E.F.7
London, E.D.8
Mukhin, A.G.9
-
33
-
-
0021339035
-
Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
-
Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Pert A., Kopin I.J. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol 1984, 100:189-194.
-
(1984)
Eur J Pharmacol
, vol.100
, pp. 189-194
-
-
Chiueh, C.C.1
Markey, S.P.2
Burns, R.S.3
Johannessen, J.N.4
Pert, A.5
Kopin, I.J.6
-
34
-
-
0021259475
-
Selective neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: A new animal model of Parkinson's disease
-
Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Jacobowitz D.M., Kopin I.J. Selective neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: A new animal model of Parkinson's disease. Psychopharmac Bull 1984, 20:548-553.
-
(1984)
Psychopharmac Bull
, vol.20
, pp. 548-553
-
-
Chiueh, C.C.1
Markey, S.P.2
Burns, R.S.3
Johannessen, J.N.4
Jacobowitz, D.M.5
Kopin, I.J.6
-
35
-
-
33947211176
-
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
-
Collier T.J., Lipton J., Daley B.F., Palfi S., Chu Y., Sortwell C., Bakay R.A., Sladek J.R., Kordower J.H. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 2007, 26:56-65.
-
(2007)
Neurobiol Dis
, vol.26
, pp. 56-65
-
-
Collier, T.J.1
Lipton, J.2
Daley, B.F.3
Palfi, S.4
Chu, Y.5
Sortwell, C.6
Bakay, R.A.7
Sladek, J.R.8
Kordower, J.H.9
-
36
-
-
0021992979
-
Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?
-
Collins M.A., Neafsey E.J. Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?. Neurosci Lett 1985, 55:179-184.
-
(1985)
Neurosci Lett
, vol.55
, pp. 179-184
-
-
Collins, M.A.1
Neafsey, E.J.2
-
37
-
-
34247189165
-
The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates
-
Cox H., Togasaki D.M., Chen L., Langston J.W., Di Monte D.A., Quik M. The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Exp Neurol 2007.
-
(2007)
Exp Neurol
-
-
Cox, H.1
Togasaki, D.M.2
Chen, L.3
Langston, J.W.4
Di Monte, D.A.5
Quik, M.6
-
38
-
-
0037704408
-
Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum
-
Cragg S.J. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. Trends Neurosci 2003, 23:4378-4385.
-
(2003)
Trends Neurosci
, vol.23
, pp. 4378-4385
-
-
Cragg, S.J.1
-
39
-
-
0021849088
-
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey
-
Crossman A.R., Mitchell I.J., Sambrook M.A. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacology 1985, 24:587-591.
-
(1985)
Neuropharmacology
, vol.24
, pp. 587-591
-
-
Crossman, A.R.1
Mitchell, I.J.2
Sambrook, M.A.3
-
40
-
-
0030272681
-
Evidence for the Hebbian hypothesis in experience-dependent physiological plasticity of neocortex: A critical review
-
Cruikshank S.J., Weinberger N.M. Evidence for the Hebbian hypothesis in experience-dependent physiological plasticity of neocortex: A critical review. Brain Res Rev 1996, 22:191-228.
-
(1996)
Brain Res Rev
, vol.22
, pp. 191-228
-
-
Cruikshank, S.J.1
Weinberger, N.M.2
-
41
-
-
0027153134
-
Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation
-
Cruz-Sanchez F.F., Cardozo A., Ambrosio S., Tolosa E., Mahy N. Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation. Mol Chem Neuropathol 1993, 19:163-176.
-
(1993)
Mol Chem Neuropathol
, vol.19
, pp. 163-176
-
-
Cruz-Sanchez, F.F.1
Cardozo, A.2
Ambrosio, S.3
Tolosa, E.4
Mahy, N.5
-
42
-
-
4544299513
-
Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys
-
Czoty P.W., Makriyannis A., Bergman J. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology (Berl) 2004, 175:170-178.
-
(2004)
Psychopharmacology (Berl)
, vol.175
, pp. 170-178
-
-
Czoty, P.W.1
Makriyannis, A.2
Bergman, J.3
-
43
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W., Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003, 39:889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
44
-
-
0034882387
-
Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment
-
Davidson C., Gow A.J., Lee M.K., Ellinwood E.H. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001, 36:1-22.
-
(2001)
Brain Res Brain Res Rev
, vol.36
, pp. 1-22
-
-
Davidson, C.1
Gow, A.J.2
Lee, M.K.3
Ellinwood, E.H.4
-
45
-
-
31544465246
-
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
-
Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9:251-259.
-
(2006)
Nat Neurosci
, vol.9
, pp. 251-259
-
-
Day, M.1
Wang, Z.2
Ding, J.3
An, X.4
Ingham, C.A.5
Shering, A.F.6
Wokosin, D.7
Ilijic, E.8
Sun, Z.9
Sampson, A.R.10
Mugnaini, E.11
Deutch, A.Y.12
Sesack, S.R.13
Arbuthnott, G.W.14
Surmeier, D.J.15
-
46
-
-
4544368233
-
Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates
-
Decamp E., Schneider J.S. Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates. Eur J Neurosci 2004, 20:1371-1378.
-
(2004)
Eur J Neurosci
, vol.20
, pp. 1371-1378
-
-
Decamp, E.1
Schneider, J.S.2
-
47
-
-
2942534726
-
Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys
-
Decamp E., Tinker J.P., Schneider J.S. Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys. Behav Brain Res 2004, 152:259-262.
-
(2004)
Behav Brain Res
, vol.152
, pp. 259-262
-
-
Decamp, E.1
Tinker, J.P.2
Schneider, J.S.3
-
48
-
-
0034114557
-
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model
-
Di Monte D.A., McCormack A., Petzinger G., Janson A.M., Quik M., Langston W.J. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord 2000, 15:459-466.
-
(2000)
Mov Disord
, vol.15
, pp. 459-466
-
-
Di Monte, D.A.1
McCormack, A.2
Petzinger, G.3
Janson, A.M.4
Quik, M.5
Langston, W.J.6
-
49
-
-
0032517187
-
A novel MPTP primate model of Parkinson's disease: Neurochemical and clinical changes
-
Eberling J.L., Jagust W., Taylor S., Bringas J., Pivirotto P., VanBrocklin H.F., Bankiewicz K.S. A novel MPTP primate model of Parkinson's disease: Neurochemical and clinical changes. Brain Res 1998, 805:259-262.
-
(1998)
Brain Res
, vol.805
, pp. 259-262
-
-
Eberling, J.L.1
Jagust, W.2
Taylor, S.3
Bringas, J.4
Pivirotto, P.5
VanBrocklin, H.F.6
Bankiewicz, K.S.7
-
50
-
-
0022511809
-
Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys
-
Eidelberg E., Brooks B.A., Morgan W.W., Walden J.G., Kokemoor R.H. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys. Neurosci 1986, 18:817-822.
-
(1986)
Neurosci
, vol.18
, pp. 817-822
-
-
Eidelberg, E.1
Brooks, B.A.2
Morgan, W.W.3
Walden, J.G.4
Kokemoor, R.H.5
-
51
-
-
0024850382
-
Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions
-
Elsworth J.D., Deutch A.Y., et al. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience 1989, 33(2):323-331.
-
(1989)
Neuroscience
, vol.33
, Issue.2
, pp. 323-331
-
-
Elsworth, J.D.1
Deutch, A.Y.2
-
52
-
-
0025194696
-
MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubal field of symptomatic and asymptomatic vervet monkeys
-
Elsworth J.D., Deutch A.Y., Redmond D.E., Sladek J.R., Roth R.H. MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubal field of symptomatic and asymptomatic vervet monkeys. Brain Res 1990, 513:320-324.
-
(1990)
Brain Res
, vol.513
, pp. 320-324
-
-
Elsworth, J.D.1
Deutch, A.Y.2
Redmond, D.E.3
Sladek, J.R.4
Roth, R.H.5
-
53
-
-
0032738101
-
Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment
-
Elsworth J.D., Taylor J.R., Sladek J.R., Collier T.J., Redmond D.E., Roth R.H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neurosci 2000, 95:399-408.
-
(2000)
Neurosci
, vol.95
, pp. 399-408
-
-
Elsworth, J.D.1
Taylor, J.R.2
Sladek, J.R.3
Collier, T.J.4
Redmond, D.E.5
Roth, R.H.6
-
54
-
-
33746095359
-
Basal ganglia lesions after MPTP administration in rhesus monkeys
-
Emborg M.E., Moirano J., Schafernak K.T., Moirano M., Evans M., Konecny T., Roitberg B., Ambarish P., Mangubat E., Ma Y., Eidelberg D., Holden J., Kordower J.H., Leestma J.E. Basal ganglia lesions after MPTP administration in rhesus monkeys. Neurobiol Dis 2006, 23:281-289.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 281-289
-
-
Emborg, M.E.1
Moirano, J.2
Schafernak, K.T.3
Moirano, M.4
Evans, M.5
Konecny, T.6
Roitberg, B.7
Ambarish, P.8
Mangubat, E.9
Ma, Y.10
Eidelberg, D.11
Holden, J.12
Kordower, J.H.13
Leestma, J.E.14
-
55
-
-
28144449393
-
Marmoset monkey models of Parkinson's disease: Which model, when and why?
-
Eslamboli A. Marmoset monkey models of Parkinson's disease: Which model, when and why?. Brain Res Bull 2005, 68:140-149.
-
(2005)
Brain Res Bull
, vol.68
, pp. 140-149
-
-
Eslamboli, A.1
-
56
-
-
33947127695
-
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
-
Eslamboli A., Romero-Ramos M., Burger C., Bjorklund T., Muzyczka N., Mandel R.J., Baker H., Ridley R.M., Kirik D. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 2007, 130:799-815.
-
(2007)
Brain
, vol.130
, pp. 799-815
-
-
Eslamboli, A.1
Romero-Ramos, M.2
Burger, C.3
Bjorklund, T.4
Muzyczka, N.5
Mandel, R.J.6
Baker, H.7
Ridley, R.M.8
Kirik, D.9
-
57
-
-
0029981526
-
Neuropathology of Parkinson's disease
-
Forno L.S. Neuropathology of Parkinson's disease. J Neuropath Exp Neurol 1996, 55:259-272.
-
(1996)
J Neuropath Exp Neurol
, vol.55
, pp. 259-272
-
-
Forno, L.S.1
-
58
-
-
0002538260
-
Neuropathology of MPTP-treated monkeys. Comparison with the neuropathology of human idiopathic Parkinson's Disease
-
Academic Press, S.P. Markey, N.J. Castagnoli, A.J. Trevor, I.J. Kopin (Eds.)
-
Forno L.S., DeLanney L.E., Irwin I., Langston J.W. Neuropathology of MPTP-treated monkeys. Comparison with the neuropathology of human idiopathic Parkinson's Disease. MPTP: A Neurotoxin Producing a Parkinsonian Syndrom 1986, 119-139. Academic Press. S.P. Markey, N.J. Castagnoli, A.J. Trevor, I.J. Kopin (Eds.).
-
(1986)
MPTP: A Neurotoxin Producing a Parkinsonian Syndrom
, pp. 119-139
-
-
Forno, L.S.1
DeLanney, L.E.2
Irwin, I.3
Langston, J.W.4
-
59
-
-
0022466381
-
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys
-
Forno L.S., Langston J.W., DeLanney L.E., Irwin I., Ricaurte G.A. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 1986, 20:449-455.
-
(1986)
Ann Neurol
, vol.20
, pp. 449-455
-
-
Forno, L.S.1
Langston, J.W.2
DeLanney, L.E.3
Irwin, I.4
Ricaurte, G.A.5
-
60
-
-
0027343340
-
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations
-
Forno L.S., DeLanney L.E., Irwin I., Langston J.W. Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Adv Neurol 1993, 60:600-608.
-
(1993)
Adv Neurol
, vol.60
, pp. 600-608
-
-
Forno, L.S.1
DeLanney, L.E.2
Irwin, I.3
Langston, J.W.4
-
61
-
-
0036868444
-
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
-
Fox S.H., Henry B., Hill M., Crossman A., Brotchie J. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord 2002, 17:1180-1187.
-
(2002)
Mov Disord
, vol.17
, pp. 1180-1187
-
-
Fox, S.H.1
Henry, B.2
Hill, M.3
Crossman, A.4
Brotchie, J.5
-
62
-
-
0002312445
-
Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP induced parkinsonism
-
MacMillan Press, London, P.M. Beart, G.N. Woodruff (Eds.)
-
Freed C.R., Richards J.B., Sabol K.E., Reite M.L. Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP induced parkinsonism. Jackson DMPharmacology and Functional Regulation of Dopaminergic Neurons 1988, 353-360. MacMillan Press, London. P.M. Beart, G.N. Woodruff (Eds.).
-
(1988)
Jackson DMPharmacology and Functional Regulation of Dopaminergic Neurons
, pp. 353-360
-
-
Freed, C.R.1
Richards, J.B.2
Sabol, K.E.3
Reite, M.L.4
-
63
-
-
0025334964
-
Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures
-
Friedman L.K., Mytilineou C. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures. J Pharmacol Exp Ther 1990, 253:892-898.
-
(1990)
J Pharmacol Exp Ther
, vol.253
, pp. 892-898
-
-
Friedman, L.K.1
Mytilineou, C.2
-
64
-
-
0028918337
-
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism
-
Frohna P.A., Rothblat D.S., Joyce J.N., Schneider J.S. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse 1995, 19:46-55.
-
(1995)
Synapse
, vol.19
, pp. 46-55
-
-
Frohna, P.A.1
Rothblat, D.S.2
Joyce, J.N.3
Schneider, J.S.4
-
65
-
-
0033668942
-
Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: A hypothesis
-
Frost D.O., Cadet J.L. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: A hypothesis. Brain Res Brain Res Rev 2000, 34:103-118.
-
(2000)
Brain Res Brain Res Rev
, vol.34
, pp. 103-118
-
-
Frost, D.O.1
Cadet, J.L.2
-
66
-
-
0030877835
-
Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter
-
Gainetdinov R.R., Fumagalli F., et al. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem. 1997, 69(3):1322-1325.
-
(1997)
J Neurochem.
, vol.69
, Issue.3
, pp. 1322-1325
-
-
Gainetdinov, R.R.1
Fumagalli, F.2
-
67
-
-
0029845140
-
Animal models of Parkinson's disease: An empiracal comparison with the phenomenology of the disease in man
-
Gerlach M., Reiderer P. Animal models of Parkinson's disease: An empiracal comparison with the phenomenology of the disease in man. J Neural Transm 1996, 103:987-1041.
-
(1996)
J Neural Transm
, vol.103
, pp. 987-1041
-
-
Gerlach, M.1
Reiderer, P.2
-
68
-
-
0023830780
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macca fasicularis: Which midbrain dopaminergic neurons are lost?
-
German D., Dubach M., Askari S., Speciale S., Bowden D. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macca fasicularis: Which midbrain dopaminergic neurons are lost?. Neurosci 1988, 24:161-174.
-
(1988)
Neurosci
, vol.24
, pp. 161-174
-
-
German, D.1
Dubach, M.2
Askari, S.3
Speciale, S.4
Bowden, D.5
-
69
-
-
0036615887
-
Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease
-
Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002, 22:4639-4653.
-
(2002)
J Neurosci
, vol.22
, pp. 4639-4653
-
-
Goldberg, J.A.1
Boraud, T.2
Maraton, S.3
Haber, S.N.4
Vaadia, E.5
Bergman, H.6
-
70
-
-
0035693854
-
Is methamphetamine abuse a risk factor in parkinsonism?
-
Guilarte T.R. Is methamphetamine abuse a risk factor in parkinsonism?. Neurotoxicol 2001, 22:725-731.
-
(2001)
Neurotoxicol
, vol.22
, pp. 725-731
-
-
Guilarte, T.R.1
-
71
-
-
14744290753
-
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
-
Hallett P.J., Dunah A.W., Ravenscroft P., Zhou S., Bezard E., Crossman A.R., Brotchie J.M., Standaert D.G. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 2005, 48:503-516.
-
(2005)
Neuropharmacology
, vol.48
, pp. 503-516
-
-
Hallett, P.J.1
Dunah, A.W.2
Ravenscroft, P.3
Zhou, S.4
Bezard, E.5
Crossman, A.R.6
Brotchie, J.M.7
Standaert, D.G.8
-
72
-
-
0027535984
-
Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
-
Hantraye P., Varastet M., Peschanski M., Riche D., Cesaro P., Willer J.C., Maziere M. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neurosci 1993, 53:169-178.
-
(1993)
Neurosci
, vol.53
, pp. 169-178
-
-
Hantraye, P.1
Varastet, M.2
Peschanski, M.3
Riche, D.4
Cesaro, P.5
Willer, J.C.6
Maziere, M.7
-
73
-
-
0033911724
-
Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure
-
Harvey D.C., Lacan G., Melega W.P. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res 2000, 133:349-358.
-
(2000)
Exp Brain Res
, vol.133
, pp. 349-358
-
-
Harvey, D.C.1
Lacan, G.2
Melega, W.P.3
-
74
-
-
0034698409
-
Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss
-
Harvey D.C., Lacan G., Tanious S.P., Melega W.P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000, 871:259-270.
-
(2000)
Brain Res
, vol.871
, pp. 259-270
-
-
Harvey, D.C.1
Lacan, G.2
Tanious, S.P.3
Melega, W.P.4
-
75
-
-
0032145369
-
Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease
-
Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: Model of aging and neurodegenerative disease. J Neurosci 1998, 18:5614-5629.
-
(1998)
J Neurosci
, vol.18
, pp. 5614-5629
-
-
Ho, A.1
Blum, M.2
-
76
-
-
6344272628
-
Effect of the D3 Dopamine Receptor Partial Agonist BP897 on L-dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys
-
Hsu A., Togasaki D.M., Bezard E., Sokoloff P., Langston J.W., Di Monte D.A., Quik M. Effect of the D3 Dopamine Receptor Partial Agonist BP897 on L-dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys. J Pharmacol Exp Ther 2004, 311:770-777.
-
(2004)
J Pharmacol Exp Ther
, vol.311
, pp. 770-777
-
-
Hsu, A.1
Togasaki, D.M.2
Bezard, E.3
Sokoloff, P.4
Langston, J.W.5
Di Monte, D.A.6
Quik, M.7
-
77
-
-
0035809803
-
Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease
-
Hurley M.J., Mash D.C., Jenner P. Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease. Brain Res Mol Brain Res 2001, 87:271-279.
-
(2001)
Brain Res Mol Brain Res
, vol.87
, pp. 271-279
-
-
Hurley, M.J.1
Mash, D.C.2
Jenner, P.3
-
78
-
-
21844449693
-
Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets
-
Hurley M.J., Jackson M.J., Smith L.A., Rose S., Jenner P. Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets. Eur J Neurosci 2005, 21:3240-3250.
-
(2005)
Eur J Neurosci
, vol.21
, pp. 3240-3250
-
-
Hurley, M.J.1
Jackson, M.J.2
Smith, L.A.3
Rose, S.4
Jenner, P.5
-
79
-
-
0033993550
-
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
-
Imbert C., Bezard E., Guitraud S., Boraud T., Gross C.E. Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Method 2000, 96:71-76.
-
(2000)
J Neurosci Method
, vol.96
, pp. 71-76
-
-
Imbert, C.1
Bezard, E.2
Guitraud, S.3
Boraud, T.4
Gross, C.E.5
-
80
-
-
0021893794
-
Selective accumulation of MPP+ in the substantianigra: a key to neurotoxicity?
-
Irwin I., Langston J.W. Selective accumulation of MPP+ in the substantianigra: a key to neurotoxicity?. Life Sci. 1985, 36(3):207-212.
-
(1985)
Life Sci.
, vol.36
, Issue.3
, pp. 207-212
-
-
Irwin, I.1
Langston, J.W.2
-
81
-
-
0025088849
-
The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey
-
Irwin I., DeLanney L.E., Forno L.S., Finnegan K.T., Di Monte D., Langston J.W. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Brain Res 1990, 531:242-252.
-
(1990)
Brain Res
, vol.531
, pp. 242-252
-
-
Irwin, I.1
DeLanney, L.E.2
Forno, L.S.3
Finnegan, K.T.4
Di Monte, D.5
Langston, J.W.6
-
82
-
-
38649126183
-
Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications
-
Israel Z., Bergman H. Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications. NeurosciBiobehav Rev. 2008, 32(3):367-377.
-
(2008)
NeurosciBiobehav Rev.
, vol.32
, Issue.3
, pp. 367-377
-
-
Israel, Z.1
Bergman, H.2
-
83
-
-
21744440118
-
MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity
-
Jackson-Lewis V., Smeyne R.J. MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview. Neurotox Res, 2005, 7:193-202.
-
(2005)
Minireview. Neurotox Res
, vol.7
, pp. 193-202
-
-
Jackson-Lewis, V.1
Smeyne, R.J.2
-
84
-
-
34347259269
-
Protocol for the MPTP mouse model of Parkinson's disease
-
Jackson-Lewis V., Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007, 2:141-151.
-
(2007)
Nat Protoc
, vol.2
, pp. 141-151
-
-
Jackson-Lewis, V.1
Przedborski, S.2
-
85
-
-
0028784523
-
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegen 1995, 4:257-269.
-
(1995)
Neurodegen
, vol.4
, pp. 257-269
-
-
Jackson-Lewis, V.1
Jakowec, M.2
Burke, R.E.3
Przedborski, S.4
-
86
-
-
0037713403
-
Neuroplasticity in the MPTP-lesioned mouse and non-human primate
-
Jakowec M.W., Fisher B., Nixon K., Hogg L., Meshul C., Bremmer S., McNeill T., Petzinger G.M. Neuroplasticity in the MPTP-lesioned mouse and non-human primate. Ann NY Acad Sci 2003, 991:298-301.
-
(2003)
Ann NY Acad Sci
, vol.991
, pp. 298-301
-
-
Jakowec, M.W.1
Fisher, B.2
Nixon, K.3
Hogg, L.4
Meshul, C.5
Bremmer, S.6
McNeill, T.7
Petzinger, G.M.8
-
87
-
-
2342503324
-
Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuro-degeneration in the mouse nigrostriatal pathway
-
Jakowec M.W., Nixon K., Hogg L., McNeill T., Petzinger G.M. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuro-degeneration in the mouse nigrostriatal pathway. J Neurosci Res 2004, 76:539-550.
-
(2004)
J Neurosci Res
, vol.76
, pp. 539-550
-
-
Jakowec, M.W.1
Nixon, K.2
Hogg, L.3
McNeill, T.4
Petzinger, G.M.5
-
88
-
-
0035233512
-
The pathology of Parkinson's disease
-
Jellinger K.A. The pathology of Parkinson's disease. Adv Neurol 2001, 86:55-72.
-
(2001)
Adv Neurol
, vol.86
, pp. 55-72
-
-
Jellinger, K.A.1
-
89
-
-
0037269421
-
The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease
-
Jenner P. The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease. Parkinsonism Relat. Disord. 2003, 9(3):131-137.
-
(2003)
Parkinsonism Relat. Disord.
, vol.9
, Issue.3
, pp. 131-137
-
-
Jenner, P.1
-
90
-
-
0006460747
-
MPTP-induced parkinsonism as an experimental model of Parkinson's disease
-
Urban and Schwarzenberg, Inc, Baltimore, J. Jankovic, E. Tolosa (Eds.)
-
Jenner P., Marsden C.D. MPTP-induced parkinsonism as an experimental model of Parkinson's disease. Parkinson's Disease and Movement Disorders 1988, 37-48. Urban and Schwarzenberg, Inc, Baltimore. J. Jankovic, E. Tolosa (Eds.).
-
(1988)
Parkinson's Disease and Movement Disorders
, pp. 37-48
-
-
Jenner, P.1
Marsden, C.D.2
-
91
-
-
0023173617
-
MPTP-induced parkinsonism in the common marmoset: Behavioral and biochemical effects
-
Jenner P., Rose S., Nomoto M., Marsden C.D. MPTP-induced parkinsonism in the common marmoset: Behavioral and biochemical effects. Adv Neurol 1986, 45:183-186.
-
(1986)
Adv Neurol
, vol.45
, pp. 183-186
-
-
Jenner, P.1
Rose, S.2
Nomoto, M.3
Marsden, C.D.4
-
92
-
-
0024456094
-
Regulation of the mesocortocolimbic dopamine system by glutamic acid receptor subtypes
-
Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocortocolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Therap 1989, 251:378-387.
-
(1989)
J Pharmacol Exp Therap
, vol.251
, pp. 378-387
-
-
Kalivas, P.W.1
Duffy, P.2
Barrow, J.3
-
93
-
-
0031594271
-
Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
-
Kanda T., Jackson M.J., Smith L.A., Pearce R.K., Nakamura J., Kase H., Kuwana Y., Jenner P. Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 1998, 43:507-513.
-
(1998)
Ann Neurol
, vol.43
, pp. 507-513
-
-
Kanda, T.1
Jackson, M.J.2
Smith, L.A.3
Pearce, R.K.4
Nakamura, J.5
Kase, H.6
Kuwana, Y.7
Jenner, P.8
-
94
-
-
0033822859
-
Abnormal neuronal and glial argyrophilic fibrillary structures in the brain of an aged albino cynomolgus monkey (Macaca fascicularis)
-
Kiatipattanasakul W., Nakayama H., Yongsiri S., Chotiapisitkul S., Nakamura S., Kojima H., Doi K. Abnormal neuronal and glial argyrophilic fibrillary structures in the brain of an aged albino cynomolgus monkey (Macaca fascicularis). Acta Neuropathol (Berl) 2000, 100:580-586.
-
(2000)
Acta Neuropathol (Berl)
, vol.100
, pp. 580-586
-
-
Kiatipattanasakul, W.1
Nakayama, H.2
Yongsiri, S.3
Chotiapisitkul, S.4
Nakamura, S.5
Kojima, H.6
Doi, K.7
-
95
-
-
0342614913
-
Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat Parkinsonian model
-
Kim B.G., Shin D.H., Jeon G.S., Seo J.H., Kim Y.W., Jeon B.S., Cho S.S. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat Parkinsonian model. Brain Res 2000, 855:162-165.
-
(2000)
Brain Res
, vol.855
, pp. 162-165
-
-
Kim, B.G.1
Shin, D.H.2
Jeon, G.S.3
Seo, J.H.4
Kim, Y.W.5
Jeon, B.S.6
Cho, S.S.7
-
96
-
-
0034090891
-
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
-
Konitsiotis S., Blanchet P.J., Verhagen L., Lamers E., Chase T.N. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 2000, 54:1589-1595.
-
(2000)
Neurology
, vol.54
, pp. 1589-1595
-
-
Konitsiotis, S.1
Blanchet, P.J.2
Verhagen, L.3
Lamers, E.4
Chase, T.N.5
-
97
-
-
0034721690
-
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
-
Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
-
(2000)
Science
, vol.290
, pp. 767-773
-
-
Kordower, J.H.1
Emborg, M.E.2
Bloch, J.3
Ma, S.Y.4
Chu, Y.5
Leventhal, L.6
McBride, J.7
Chen, E.Y.8
Palfi, S.9
Roitberg, B.Z.10
Brown, W.D.11
Holden, J.E.12
Pyzalski, R.13
Taylor, M.D.14
Carvey, P.15
Ling, Z.16
Trono, D.17
Hantraye, P.18
Deglon, N.19
Aebischer, P.20
more..
-
98
-
-
33746851988
-
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys
-
Kordower J.H., Kanaan N.M., Chu Y., Suresh Babu R., Stansell J., Terpstra B.T., Sortwell C.E., Steece-Collier K., Collier T.J. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol 2006, 60:264-268.
-
(2006)
Ann Neurol
, vol.60
, pp. 264-268
-
-
Kordower, J.H.1
Kanaan, N.M.2
Chu, Y.3
Suresh Babu, R.4
Stansell, J.5
Terpstra, B.T.6
Sortwell, C.E.7
Steece-Collier, K.8
Collier, T.J.9
-
99
-
-
33846908287
-
Endocan-nabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
-
Kreitzer A.C., Malenka R.C. Endocan-nabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
-
(2007)
Nature
, vol.445
, pp. 643-647
-
-
Kreitzer, A.C.1
Malenka, R.C.2
-
100
-
-
34548175402
-
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates
-
Kuoppamaki M., Al-Barghouthy G., Jackson M.J., Smith L.A., Quinn N., Jenner P. L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates. J Neural Transm 2007.
-
(2007)
J Neural Transm
-
-
Kuoppamaki, M.1
Al-Barghouthy, G.2
Jackson, M.J.3
Smith, L.A.4
Quinn, N.5
Jenner, P.6
-
101
-
-
0025771971
-
The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys
-
Kurlan R., Kim M.H., Gash D.M. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Ann Neurol 1991, 29:677-679.
-
(1991)
Ann Neurol
, vol.29
, pp. 677-679
-
-
Kurlan, R.1
Kim, M.H.2
Gash, D.M.3
-
102
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
-
Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.2
Tetrud, J.W.3
Irwin, I.4
-
103
-
-
0021337873
-
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine (MPTP) in the squirrel monkey
-
Langston J.W., Forno S., Rebert C.S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 1984, 292:390-394.
-
(1984)
Brain Res
, vol.292
, pp. 390-394
-
-
Langston, J.W.1
Forno, S.2
Rebert, C.S.3
Irwin, I.4
-
104
-
-
3242686149
-
Corticostriatal plasticity: Life after the depression
-
Mahon S., Deniau J.M., Charpier S. Corticostriatal plasticity: Life after the depression. Trends Neurosci 2004, 27:460-467.
-
(2004)
Trends Neurosci
, vol.27
, pp. 460-467
-
-
Mahon, S.1
Deniau, J.M.2
Charpier, S.3
-
105
-
-
33746791044
-
Lack of nigrostriatal pathology in a rat model of proteasome inhibition
-
Manning-Bog A.B., Reaney S.H., Chou V.P., Johnston L.C., McCormack A.L., Johnston J., Langston J.W., Di Monte D.A. Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Ann Neurol 2006, 60:256-260.
-
(2006)
Ann Neurol
, vol.60
, pp. 256-260
-
-
Manning-Bog, A.B.1
Reaney, S.H.2
Chou, V.P.3
Johnston, L.C.4
McCormack, A.L.5
Johnston, J.6
Langston, J.W.7
Di Monte, D.A.8
-
106
-
-
0021137683
-
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
-
Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 1984, 311:464-467.
-
(1984)
Nature
, vol.311
, pp. 464-467
-
-
Markey, S.P.1
Johannessen, J.N.2
Chiueh, C.C.3
Burns, R.S.4
Herkenham, M.A.5
-
107
-
-
0032531781
-
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428
-
McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998, 18:8417-8422.
-
(1998)
J Neurosci
, vol.18
, pp. 8417-8422
-
-
McCann, U.D.1
Wong, D.F.2
Yokoi, F.3
Villemagne, V.4
Dannals, R.F.5
Ricaurte, G.A.6
-
108
-
-
0030984414
-
Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey
-
Melega W.P., Raleigh M.J., Stout D.B., Lacan G., Huang S.-C., Phelps M.E. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res 1997, 766:113-120.
-
(1997)
Brain Res
, vol.766
, pp. 113-120
-
-
Melega, W.P.1
Raleigh, M.J.2
Stout, D.B.3
Lacan, G.4
Huang, S.-C.5
Phelps, M.E.6
-
109
-
-
0037159608
-
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
-
Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison R.C., Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 2002, 956:156-165.
-
(2002)
Brain Res
, vol.956
, pp. 156-165
-
-
Meredith, G.E.1
Totterdell, S.2
Petroske, E.3
Santa Cruz, K.4
Callison, R.C.5
Lau, Y.S.6
-
110
-
-
0022350722
-
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus
-
Mitchell I.J., Cross A.J., Sambrook M.A., Crossman A.R. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett 1985, 61:195-200.
-
(1985)
Neurosci Lett
, vol.61
, pp. 195-200
-
-
Mitchell, I.J.1
Cross, A.J.2
Sambrook, M.A.3
Crossman, A.R.4
-
111
-
-
0032581386
-
Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice
-
Mitsumoto Y., Watanabe A., Mori A., Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Biochem Biophys Res Comm 1998, 248:660-663.
-
(1998)
Biochem Biophys Res Comm
, vol.248
, pp. 660-663
-
-
Mitsumoto, Y.1
Watanabe, A.2
Mori, A.3
Koga, N.4
-
112
-
-
0022922179
-
Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine
-
Moerlein S.M., Stocklin G., Pawlik G., Wienhard K., Heiss W.D. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine. Neurosci Lett 1986, 66:205-209.
-
(1986)
Neurosci Lett
, vol.66
, pp. 205-209
-
-
Moerlein, S.M.1
Stocklin, G.2
Pawlik, G.3
Wienhard, K.4
Heiss, W.D.5
-
113
-
-
0026587806
-
Differential vulnerability of primate caudate-putament and striosime-matrix dopamie systems to the neurotoxic effects of 1-methyl-4-1,2,3,6-tetrahydropyridine
-
Moratalla R., Quinn B., DeLanney L.E., Irwin I., Langston J.W., Graybiel A.M. Differential vulnerability of primate caudate-putament and striosime-matrix dopamie systems to the neurotoxic effects of 1-methyl-4-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1992, 89:3859-3863.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 3859-3863
-
-
Moratalla, R.1
Quinn, B.2
DeLanney, L.E.3
Irwin, I.4
Langston, J.W.5
Graybiel, A.M.6
-
114
-
-
0025786135
-
Changes in the nigrostriatal projections associated with recovery from lesion-induced behavioral asymmetry
-
Morgan S., Nomikos G., Huston J.P. Changes in the nigrostriatal projections associated with recovery from lesion-induced behavioral asymmetry. Behav Brain Res 1991, 46:157-165.
-
(1991)
Behav Brain Res
, vol.46
, pp. 157-165
-
-
Morgan, S.1
Nomikos, G.2
Huston, J.P.3
-
115
-
-
0023922934
-
Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies
-
Mori S., Fujitake J., Kuno S., Sano Y. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci Lett 1988, 90:57-62.
-
(1988)
Neurosci Lett
, vol.90
, pp. 57-62
-
-
Mori, S.1
Fujitake, J.2
Kuno, S.3
Sano, Y.4
-
116
-
-
0035353763
-
Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
-
Muriel M.P., Agid Y., Hirsch E. Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease. Mov Disord 2001, 16:435-441.
-
(2001)
Mov Disord
, vol.16
, pp. 435-441
-
-
Muriel, M.P.1
Agid, Y.2
Hirsch, E.3
-
117
-
-
0023215260
-
MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons
-
Namura I., Douillet P., Sun C.J., Pert A., Cohen R.M., Chiueh C.C. MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Eur J Pharmacol 1987, 136:31-37.
-
(1987)
Eur J Pharmacol
, vol.136
, pp. 31-37
-
-
Namura, I.1
Douillet, P.2
Sun, C.J.3
Pert, A.4
Cohen, R.M.5
Chiueh, C.C.6
-
118
-
-
3042833166
-
The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease
-
Nash J.E., Ravenscroft P., McGuire S., Crossman A.R., Menniti F.S., Brotchie J.M. The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease. Exp Neurol 2004, 188:471-479.
-
(2004)
Exp Neurol
, vol.188
, pp. 471-479
-
-
Nash, J.E.1
Ravenscroft, P.2
McGuire, S.3
Crossman, A.R.4
Menniti, F.S.5
Brotchie, J.M.6
-
119
-
-
0024393971
-
Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: A comparison of young and older mice
-
Nishi K., Kondo T., Narabayashi H. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: A comparison of young and older mice. Brain Res 1989, 489:157-162.
-
(1989)
Brain Res
, vol.489
, pp. 157-162
-
-
Nishi, K.1
Kondo, T.2
Narabayashi, H.3
-
120
-
-
33745499251
-
Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys
-
discussion 275-266
-
Oiwa Y., Nakai K., Itakura T. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys. Neurol Med Chir (Tokyo) 2006, 46:267-275. discussion 275-266.
-
(2006)
Neurol Med Chir (Tokyo)
, vol.46
, pp. 267-275
-
-
Oiwa, Y.1
Nakai, K.2
Itakura, T.3
-
121
-
-
4043111360
-
Overlesioned hemiparkinsonian non human primate model: Correlation between clinical, neurochemical and histochemical changes
-
Oiwa Y., Eberling J.L., Nagy D., Pivirotto P., Emborg M.E., Bankiewicz K.S. Overlesioned hemiparkinsonian non human primate model: Correlation between clinical, neurochemical and histochemical changes. Front Biosci 2003, 8:155-166.
-
(2003)
Front Biosci
, vol.8
, pp. 155-166
-
-
Oiwa, Y.1
Eberling, J.L.2
Nagy, D.3
Pivirotto, P.4
Emborg, M.E.5
Bankiewicz, K.S.6
-
122
-
-
0029597780
-
Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
-
Ovadia A., Zhang Z., Gash D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995, 16:931-937.
-
(1995)
Neurobiol Aging
, vol.16
, pp. 931-937
-
-
Ovadia, A.1
Zhang, Z.2
Gash, D.M.3
-
123
-
-
0029665122
-
Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys
-
Papa S.M., Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol 1996, 39:574-578.
-
(1996)
Ann Neurol
, vol.39
, pp. 574-578
-
-
Papa, S.M.1
Chase, T.N.2
-
124
-
-
0033822025
-
Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum
-
Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 2000, 84:1422-1429.
-
(2000)
J Neurophysiol
, vol.84
, pp. 1422-1429
-
-
Partridge, J.G.1
Tang, K.C.2
Lovinger, D.M.3
-
125
-
-
0036149285
-
Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects
-
Paulus M.P., Hozack N.E., Zauscher B.E., Frank L., Brown G.G., Braff D.L., Schuckit M.A. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 2002, 26:53-65.
-
(2002)
Neuropsychopharmacology
, vol.26
, pp. 53-65
-
-
Paulus, M.P.1
Hozack, N.E.2
Zauscher, B.E.3
Frank, L.4
Brown, G.G.5
Braff, D.L.6
Schuckit, M.A.7
-
126
-
-
0034935182
-
L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations
-
Pearce R.K., Heikkila M., Linden I.B., Jenner P. L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations. Psychopharmacology (Berl) 2001, 156:402-409.
-
(2001)
Psychopharmacology (Berl)
, vol.156
, pp. 402-409
-
-
Pearce, R.K.1
Heikkila, M.2
Linden, I.B.3
Jenner, P.4
-
127
-
-
0025837179
-
Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset
-
Perez-Otano I., Herrero M.T., Oset C., De Ceballos M.L., Luquin M.R., Obeso J.A., Del Rio J. Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res 1991, 567:127-132.
-
(1991)
Brain Res
, vol.567
, pp. 127-132
-
-
Perez-Otano, I.1
Herrero, M.T.2
Oset, C.3
De Ceballos, M.L.4
Luquin, M.R.5
Obeso, J.A.6
Del Rio, J.7
-
128
-
-
2942708228
-
Mechanism of neurodegenerative disease: Role of the ubiquitin proteasome system
-
Petrucelli L., Dawson T.M. Mechanism of neurodegenerative disease: Role of the ubiquitin proteasome system. Ann Med 2004, 36:315-320.
-
(2004)
Ann Med
, vol.36
, pp. 315-320
-
-
Petrucelli, L.1
Dawson, T.M.2
-
129
-
-
0001418286
-
The MPTP-lesioned non-human primate: A model for Parkinson' s disease
-
Prominent Press, Scottsdale, AZ, J. Marwah, H. Teitelbbaum (Eds.)
-
Petzinger G.M., Langston J.W. The MPTP-lesioned non-human primate: A model for Parkinson' s disease. Advances in Neurodegenerative Disease. Volume I: Parkinson's Disease 1998, 113-148. Prominent Press, Scottsdale, AZ. J. Marwah, H. Teitelbbaum (Eds.).
-
(1998)
Advances in Neurodegenerative Disease. Volume I: Parkinson's Disease
, pp. 113-148
-
-
Petzinger, G.M.1
Langston, J.W.2
-
130
-
-
0035297120
-
Reliability and validity of a new global dyskinesia rating scale in MPTP-lesioned non-human primate
-
Petzinger G.M., Quik M., Ivashina E., Jakowec M.W., Jakubiak M., Di Monte D., Langston J.W. Reliability and validity of a new global dyskinesia rating scale in MPTP-lesioned non-human primate. Mov Disord 2001, 16:202-207.
-
(2001)
Mov Disord
, vol.16
, pp. 202-207
-
-
Petzinger, G.M.1
Quik, M.2
Ivashina, E.3
Jakowec, M.W.4
Jakubiak, M.5
Di Monte, D.6
Langston, J.W.7
-
131
-
-
31844445273
-
Behavioral Recovery in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-lesioned Squirrel Monkey (Saimiri sciureus): Analysis of Striatal Dopamine and the Expression of Tyrosine Hydroxylase and Dopamine Transporter Proteins
-
Petzinger G.M., Fisher B.E., Hogg E., Abernathy A., Arevalo P., Nixon K., Jakowec M.W. Behavioral Recovery in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-lesioned Squirrel Monkey (Saimiri sciureus): Analysis of Striatal Dopamine and the Expression of Tyrosine Hydroxylase and Dopamine Transporter Proteins. J Neuorsci Res 2006, 83:332-347.
-
(2006)
J Neuorsci Res
, vol.83
, pp. 332-347
-
-
Petzinger, G.M.1
Fisher, B.E.2
Hogg, E.3
Abernathy, A.4
Arevalo, P.5
Nixon, K.6
Jakowec, M.W.7
-
132
-
-
26444462104
-
Pathological synaptic plasticity in the striatum: Implications for Parkinson's disease
-
Picconi B., Pisani A., Barone I., Bonsi P., Centonze D., Bernardi G., Calabresi P. Pathological synaptic plasticity in the striatum: Implications for Parkinson's disease. Neurotoxicology 2005, 26:779-783.
-
(2005)
Neurotoxicology
, vol.26
, pp. 779-783
-
-
Picconi, B.1
Pisani, A.2
Barone, I.3
Bonsi, P.4
Centonze, D.5
Bernardi, G.6
Calabresi, P.7
-
133
-
-
0035091767
-
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety
-
Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., Akram M. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety. J Neurochem 2001, 76:1265-1274.
-
(2001)
J Neurochem
, vol.76
, pp. 1265-1274
-
-
Przedborski, S.1
Jackson-Lewis, V.2
Naini, A.B.3
Jakowec, M.4
Petzinger, G.5
Miller, R.6
Akram, M.7
-
134
-
-
0034668905
-
Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism
-
Raz A., Vaadia E., Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000, 20:8559-8571.
-
(2000)
J Neurosci
, vol.20
, pp. 8559-8571
-
-
Raz, A.1
Vaadia, E.2
Bergman, H.3
-
135
-
-
0029748597
-
Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates
-
Raz A., Feingold A., Zelanskaya V., Vaadia E., Bergman H. Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates. J Neurophysiol 1996, 76:2083-2088.
-
(1996)
J Neurophysiol
, vol.76
, pp. 2083-2088
-
-
Raz, A.1
Feingold, A.2
Zelanskaya, V.3
Vaadia, E.4
Bergman, H.5
-
136
-
-
0035256903
-
Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys
-
Raz A., Frechter-Mazar V., Feingold A., Abeles M., Vaadia E., Bergman H. Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys. J Neurosci 2001, 21:RC128.
-
(2001)
J Neurosci
, vol.21
-
-
Raz, A.1
Frechter-Mazar, V.2
Feingold, A.3
Abeles, M.4
Vaadia, E.5
Bergman, H.6
-
137
-
-
0036592025
-
Dopamine-dependent plasticity of corticostriatal synapses
-
Reynolds J.N., Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw 2002, 15:507-521.
-
(2002)
Neural Netw
, vol.15
, pp. 507-521
-
-
Reynolds, J.N.1
Wickens, J.R.2
-
138
-
-
0023837672
-
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver
-
Riachi N.J., Harik S.I., Kalaria R.N., Sayre L.M. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver. J Pharmacol Exp Ther 1988, 244:443-448.
-
(1988)
J Pharmacol Exp Ther
, vol.244
, pp. 443-448
-
-
Riachi, N.J.1
Harik, S.I.2
Kalaria, R.N.3
Sayre, L.M.4
-
139
-
-
0018824851
-
Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study
-
Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 1980, 193:153-163.
-
(1980)
Brain Res
, vol.193
, pp. 153-163
-
-
Ricaurte, G.A.1
Schuster, C.R.2
Seiden, L.S.3
-
140
-
-
0020084295
-
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
-
Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 1982, 235:93-103.
-
(1982)
Brain Res
, vol.235
, pp. 93-103
-
-
Ricaurte, G.A.1
Guillery, R.W.2
Seiden, L.S.3
Schuster, C.R.4
Moore, R.Y.5
-
141
-
-
0022477535
-
Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment
-
Ricaurte G.A., Langston J.W., DeLanney L.E., Irwin I., Peroutka S.J., Forno L.S. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment. Brain Res 1986, 376:117-124.
-
(1986)
Brain Res
, vol.376
, pp. 117-124
-
-
Ricaurte, G.A.1
Langston, J.W.2
DeLanney, L.E.3
Irwin, I.4
Peroutka, S.J.5
Forno, L.S.6
-
142
-
-
0023948634
-
Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats
-
Robinson T.E., Wishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 1988, 450:209-224.
-
(1988)
Brain Res
, vol.450
, pp. 209-224
-
-
Robinson, T.E.1
Wishaw, I.Q.2
-
143
-
-
0024328184
-
Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP
-
Rose S., Nomoto M., Kelly E., Kilpatrick G., Jenner P., Marsden C.D. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neurosci Lett 1989, 101:305-310.
-
(1989)
Neurosci Lett
, vol.101
, pp. 305-310
-
-
Rose, S.1
Nomoto, M.2
Kelly, E.3
Kilpatrick, G.4
Jenner, P.5
Marsden, C.D.6
-
144
-
-
0027492176
-
Age-related effects of 1-methyl-4-phenyl-,2,3,6-tetrahydropyridine treatment of common marmosets
-
Rose S., Nomoto M., Jackson E.A., Gibb W.R.G., Jaehnig P., Jenner P., Marsden C.D. Age-related effects of 1-methyl-4-phenyl-,2,3,6-tetrahydropyridine treatment of common marmosets. Eur J Pharm 1993, 230:177-185.
-
(1993)
Eur J Pharm
, vol.230
, pp. 177-185
-
-
Rose, S.1
Nomoto, M.2
Jackson, E.A.3
Gibb, W.R.G.4
Jaehnig, P.5
Jenner, P.6
Marsden, C.D.7
-
145
-
-
0035424801
-
Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental parkinsonism
-
Rothblat D.S., Schroeder J.A., Schneider J.S. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental parkinsonism. J Neurosci Res 2001, 65:254-266.
-
(2001)
J Neurosci Res
, vol.65
, pp. 254-266
-
-
Rothblat, D.S.1
Schroeder, J.A.2
Schneider, J.S.3
-
146
-
-
0032502634
-
Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice
-
Rozas G., Liste I., Guerra M.J., Labandeira-Garcia J.L. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett 1998, 245:151-154.
-
(1998)
Neurosci Lett
, vol.245
, pp. 151-154
-
-
Rozas, G.1
Liste, I.2
Guerra, M.J.3
Labandeira-Garcia, J.L.4
-
147
-
-
0036751653
-
Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist
-
Ruel J., Guitton M.J., Puell J.L. Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist. CNS Drug Rev 2002, 8:235-254.
-
(2002)
CNS Drug Rev
, vol.8
, pp. 235-254
-
-
Ruel, J.1
Guitton, M.J.2
Puell, J.L.3
-
148
-
-
0026099265
-
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?
-
Russ H., Mihatsch W., Gerlach M., Riederer P., Przuntek H. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?. Neurosci Lett 1991, 123:115-118.
-
(1991)
Neurosci Lett
, vol.123
, pp. 115-118
-
-
Russ, H.1
Mihatsch, W.2
Gerlach, M.3
Riederer, P.4
Przuntek, H.5
-
149
-
-
0142122419
-
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems
-
Samadi P., Gregoire L., Bedard P.J. Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems. Neuropharmacology 2003, 45:954-963.
-
(2003)
Neuropharmacology
, vol.45
, pp. 954-963
-
-
Samadi, P.1
Gregoire, L.2
Bedard, P.J.3
-
150
-
-
2342576336
-
The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys
-
Samadi P., Gregoire L., Bedard P.J. The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys. Neurobiol Dis 2004, 16:246-253.
-
(2004)
Neurobiol Dis
, vol.16
, pp. 246-253
-
-
Samadi, P.1
Gregoire, L.2
Bedard, P.J.3
-
151
-
-
45849121480
-
MGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys
-
Samadi P., Gregoire L., Morissette M., Calon F., Hadj Tahar A., Dridi M., Belanger N., Meltzer L.T., Bedard P.J., Di Paolo T. mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Aging 2007.
-
(2007)
Neurobiol Aging
-
-
Samadi, P.1
Gregoire, L.2
Morissette, M.3
Calon, F.4
Hadj Tahar, A.5
Dridi, M.6
Belanger, N.7
Meltzer, L.T.8
Bedard, P.J.9
Di Paolo, T.10
-
153
-
-
0025346258
-
Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
-
Schneider J.S., Kovelowski C.J. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res 1990, 519:122-128.
-
(1990)
Brain Res
, vol.519
, pp. 122-128
-
-
Schneider, J.S.1
Kovelowski, C.J.2
-
154
-
-
0028825827
-
Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey
-
Schneider J.S., Pope-Coleman A. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 1995, 4:245-255.
-
(1995)
Neurodegeneration
, vol.4
, pp. 245-255
-
-
Schneider, J.S.1
Pope-Coleman, A.2
-
155
-
-
0028280215
-
Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism
-
Schneider J.S., Rothblat D.S., DiStefano L. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res 1994, 643:86-91.
-
(1994)
Brain Res
, vol.643
, pp. 86-91
-
-
Schneider, J.S.1
Rothblat, D.S.2
DiStefano, L.3
-
156
-
-
0028795054
-
Differential recovery of volitional motor function, lateralized cognitive function, dopamine-agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion
-
Schneider J.S., Lidsky T.I., Hawks T., Mazziotta J.C., Hoffman J.M. Differential recovery of volitional motor function, lateralized cognitive function, dopamine-agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Brain Res 1995, 672:112-127.
-
(1995)
Brain Res
, vol.672
, pp. 112-127
-
-
Schneider, J.S.1
Lidsky, T.I.2
Hawks, T.3
Mazziotta, J.C.4
Hoffman, J.M.5
-
157
-
-
0141987877
-
Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms
-
Schneider J.S., Gonczi H., Decamp E. Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms. Brain Res 2003, 990:38-44.
-
(2003)
Brain Res
, vol.990
, pp. 38-44
-
-
Schneider, J.S.1
Gonczi, H.2
Decamp, E.3
-
158
-
-
0025728002
-
Mechanism of accumulationof the 1-methyl-4-phenyl-phenylpyridinium species into mouse brain synaptosomes
-
Scotcher K.P., Irwin I., DeLanney L.E., Langston J.W., Di Monte D. Mechanism of accumulationof the 1-methyl-4-phenyl-phenylpyridinium species into mouse brain synaptosomes. J Neurochem 1991, 56:1602-1607.
-
(1991)
J Neurochem
, vol.56
, pp. 1602-1607
-
-
Scotcher, K.P.1
Irwin, I.2
DeLanney, L.E.3
Langston, J.W.4
Di Monte, D.5
-
159
-
-
0033933048
-
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
-
Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000, 25:302-305.
-
(2000)
Nat Genet
, vol.25
, pp. 302-305
-
-
Shimura, H.1
Hattori, N.2
Kubo, S.3
Mizuno, Y.4
Asakawa, S.5
Minoshima, S.6
Shimizu, N.7
Iwai, K.8
Chiba, T.9
Tanaka, K.10
Suzuki, T.11
-
160
-
-
0033031356
-
Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys
-
Slovin H., Abeles M., Vaadia E., Haalman I., Prut Y., Bergman H. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. J Neurophysiol 1999, 81:858-874.
-
(1999)
J Neurophysiol
, vol.81
, pp. 858-874
-
-
Slovin, H.1
Abeles, M.2
Vaadia, E.3
Haalman, I.4
Prut, Y.5
Bergman, H.6
-
161
-
-
0033031356
-
Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys
-
Slovin H., Abeles M., Vaadia E., Haalman I., Prut Y., Bergman H. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. J Neurophysiol 1999, 81:858-874.
-
(1999)
J Neurophysiol
, vol.81
, pp. 858-874
-
-
Slovin, H.1
Abeles, M.2
Vaadia, E.3
Haalman, I.4
Prut, Y.5
Bergman, H.6
-
162
-
-
0027492362
-
Developing a stable bilateral model of parkinsonism in rhesus monkeys
-
Smith R., Zhang Z., Kurlan R., McDermott M., Gash D. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 1993, 52:7-16.
-
(1993)
Neuroscience
, vol.52
, pp. 7-16
-
-
Smith, R.1
Zhang, Z.2
Kurlan, R.3
McDermott, M.4
Gash, D.5
-
163
-
-
0035801465
-
Regional differences in the expression of corticostriatal synaptic plasticity
-
Smith R., Musleh W., Akopian W., Buckwalter G., Walsh J.P. Regional differences in the expression of corticostriatal synaptic plasticity. Neuroscience 2001, 106:95-101.
-
(2001)
Neuroscience
, vol.106
, pp. 95-101
-
-
Smith, R.1
Musleh, W.2
Akopian, W.3
Buckwalter, G.4
Walsh, J.P.5
-
164
-
-
33746417219
-
Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates
-
Smith L.A., Jackson M.J., Johnston L., Kuoppamaki M., Rose S., Al-Barghouthy G., Del Signore S., Jenner P. Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates. Clin Neuropharmacol 2006, 29:112-125.
-
(2006)
Clin Neuropharmacol
, vol.29
, pp. 112-125
-
-
Smith, L.A.1
Jackson, M.J.2
Johnston, L.3
Kuoppamaki, M.4
Rose, S.5
Al-Barghouthy, G.6
Del Signore, S.7
Jenner, P.8
-
165
-
-
0032571742
-
Pattern of synaptophysin immunoreactivity within mesencephalic grafts following transplantation in a parkinsonian primate model
-
Sortwell C.E., Blanchard B.C., Collier T.J., Elsworth J.D., Taylor J.R., Roth R.H., Redmond D.E., Sladek J.R. Pattern of synaptophysin immunoreactivity within mesencephalic grafts following transplantation in a parkinsonian primate model. Brain Res 1998, 791:117-124.
-
(1998)
Brain Res
, vol.791
, pp. 117-124
-
-
Sortwell, C.E.1
Blanchard, B.C.2
Collier, T.J.3
Elsworth, J.D.4
Taylor, J.R.5
Roth, R.H.6
Redmond, D.E.7
Sladek, J.R.8
-
166
-
-
0034108225
-
Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata
-
Staal R., Sonsalla P. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. J Pharmacol Exp Ther. 2000, 293(2):336-342.
-
(2000)
J Pharmacol Exp Ther.
, vol.293
, Issue.2
, pp. 336-342
-
-
Staal, R.1
Sonsalla, P.2
-
167
-
-
0036764831
-
The hyperkinetic abnormal movements scale: A tool for measuring levodopa-induced abnormal movements in squirrel monkeys
-
Tan L.C., Protell P.H., Langston J.W., Togasaki D.M. The hyperkinetic abnormal movements scale: A tool for measuring levodopa-induced abnormal movements in squirrel monkeys. Mov Disord 2002, 17:902-909.
-
(2002)
Mov Disord
, vol.17
, pp. 902-909
-
-
Tan, L.C.1
Protell, P.H.2
Langston, J.W.3
Togasaki, D.M.4
-
168
-
-
9644257142
-
Ubiquitin, proteasome and parkin
-
Tanaka K., Suzuki T., Hattori N., Mizuno Y. Ubiquitin, proteasome and parkin. Biochim Biophys Acta 2004, 1695:235-247.
-
(2004)
Biochim Biophys Acta
, vol.1695
, pp. 235-247
-
-
Tanaka, K.1
Suzuki, T.2
Hattori, N.3
Mizuno, Y.4
-
169
-
-
0025913348
-
Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls
-
Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Collier T.J., Redmond D.E. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp Brain Res 1991, 85:335-348.
-
(1991)
Exp Brain Res
, vol.85
, pp. 335-348
-
-
Taylor, J.R.1
Elsworth, J.D.2
Roth, R.H.3
Sladek, J.R.4
Collier, T.J.5
Redmond, D.E.6
-
170
-
-
0002269237
-
Behavioral effects of MPTP administration in the vervet monkey. A primate model of Parkinson's disease
-
Plenum Press, New York, M.L. Woodruff, A.J. Nonneman (Eds.)
-
Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Redmond D.E. Behavioral effects of MPTP administration in the vervet monkey. A primate model of Parkinson's disease. Toxin-Induced Models of Neurological Disorders 1994, 139-174. Plenum Press, New York. M.L. Woodruff, A.J. Nonneman (Eds.).
-
(1994)
Toxin-Induced Models of Neurological Disorders
, pp. 139-174
-
-
Taylor, J.R.1
Elsworth, J.D.2
Roth, R.H.3
Sladek, J.R.4
Redmond, D.E.5
-
171
-
-
0031587263
-
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)
-
Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Redmond D.E. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience 1997, 81:745-755.
-
(1997)
Neuroscience
, vol.81
, pp. 745-755
-
-
Taylor, J.R.1
Elsworth, J.D.2
Roth, R.H.3
Sladek, J.R.4
Redmond, D.E.5
-
172
-
-
84996123497
-
MPTP-induced parkinsonism as a model for Parkinson's disease
-
Tetrud J.W., Langston J.W. MPTP-induced parkinsonism as a model for Parkinson's disease. Acta Neurol Scand 1989, 126:35-40.
-
(1989)
Acta Neurol Scand
, vol.126
, pp. 35-40
-
-
Tetrud, J.W.1
Langston, J.W.2
-
173
-
-
0000249408
-
MPTP-induced tremor in human and non-human primates
-
Tetrud J.W., Langston J.W., Redmond D.E., Roth R.H., Sladek J.R., Angel R.W. MPTP-induced tremor in human and non-human primates. Neurology 1986, 36(Suppl. 1):308.
-
(1986)
Neurology
, vol.36
, Issue.SUPPL. 1
, pp. 308
-
-
Tetrud, J.W.1
Langston, J.W.2
Redmond, D.E.3
Roth, R.H.4
Sladek, J.R.5
Angel, R.W.6
-
174
-
-
0034898907
-
Levodopa induces dyskinesias in normal squirrel monkeys
-
Togasaki D.M., Tan L., Protell P., Di Monte D.A., Quik M., Langston J.W. Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol 2001, 50:254-257.
-
(2001)
Ann Neurol
, vol.50
, pp. 254-257
-
-
Togasaki, D.M.1
Tan, L.2
Protell, P.3
Di Monte, D.A.4
Quik, M.5
Langston, J.W.6
-
175
-
-
13844266039
-
Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa
-
Togasaki D.M., Protell P., Tan L.C., Langston J.W., Di Monte D.A., Quik M. Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa. Neuropharmacology 2005, 48:398-405.
-
(2005)
Neuropharmacology
, vol.48
, pp. 398-405
-
-
Togasaki, D.M.1
Protell, P.2
Tan, L.C.3
Langston, J.W.4
Di Monte, D.A.5
Quik, M.6
-
176
-
-
0031975428
-
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease
-
Verhagen Metman L., Del Dotto P., Blanchet P.J., van den Munckhof P., Chase T.N. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids 1998, 14:75-82.
-
(1998)
Amino Acids
, vol.14
, pp. 75-82
-
-
Verhagen Metman, L.1
Del Dotto, P.2
Blanchet, P.J.3
van den Munckhof, P.4
Chase, T.N.5
-
177
-
-
17344365599
-
Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
-
Villemagne V., Yuan J., Wong D.F., Dannals R.F., Hatzidimitriou G., Mathews W.B., Ravert H.T., Musachio J., McCann U.D., Ricaurte G.A. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998, 18:419-427.
-
(1998)
J Neurosci
, vol.18
, pp. 419-427
-
-
Villemagne, V.1
Yuan, J.2
Wong, D.F.3
Dannals, R.F.4
Hatzidimitriou, G.5
Mathews, W.B.6
Ravert, H.T.7
Musachio, J.8
McCann, U.D.9
Ricaurte, G.A.10
-
178
-
-
0034105157
-
Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
-
Vitek J.L., Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia. Ann Neurol 2000, 47:S131-sS140.
-
(2000)
Ann Neurol
, vol.47
-
-
Vitek, J.L.1
Giroux, M.2
-
179
-
-
0035968065
-
Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism
-
Wade T.V., Rothblat D.S., Schneider J.S. Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism. Brain Res 2001, 905:111-119.
-
(2001)
Brain Res
, vol.905
, pp. 111-119
-
-
Wade, T.V.1
Rothblat, D.S.2
Schneider, J.S.3
-
180
-
-
33646139645
-
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons
-
Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., Tkatch T., Lovinger D.M., Surmeier D.J. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
-
(2006)
Neuron
, vol.50
, pp. 443-452
-
-
Wang, Z.1
Kai, L.2
Day, M.3
Ronesi, J.4
Yin, H.H.5
Ding, J.6
Tkatch, T.7
Lovinger, D.M.8
Surmeier, D.J.9
-
181
-
-
0023550354
-
An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset
-
Waters C.M., Hunt S.P., Jenner P., Marsden C.D. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 1987, 23:1025-1039.
-
(1987)
Neuroscience
, vol.23
, pp. 1025-1039
-
-
Waters, C.M.1
Hunt, S.P.2
Jenner, P.3
Marsden, C.D.4
-
182
-
-
0038389600
-
Pathophysiology of Parkinson's Disease: The MPTP primate model of the human disorder
-
Wichmann T., DeLong M.R. Pathophysiology of Parkinson's Disease: The MPTP primate model of the human disorder. Ann NY Acad Sci 2003, 991:199-216.
-
(2003)
Ann NY Acad Sci
, vol.991
, pp. 199-216
-
-
Wichmann, T.1
DeLong, M.R.2
-
183
-
-
0032462195
-
The effects of methamphetamine on the production of free radicals and oxidative stress
-
Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998, 287:107-114.
-
(1998)
J Pharmacol Exp Ther
, vol.287
, pp. 107-114
-
-
Yamamoto, B.K.1
Zhu, W.2
-
184
-
-
0030687682
-
Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism
-
Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol Dis 1997, 4:247-253.
-
(1997)
Neurobiol Dis
, vol.4
, pp. 247-253
-
-
Zigmond, M.J.1
-
185
-
-
0025373167
-
Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications
-
Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Sticker E.M. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends Neurosci 1990, 13:290-295.
-
(1990)
Trends Neurosci
, vol.13
, pp. 290-295
-
-
Zigmond, M.J.1
Abercrombie, E.D.2
Berger, T.W.3
Grace, A.A.4
Sticker, E.M.5
-
186
-
-
0028239552
-
In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but is not neurotoxic: A model of natural resistance to MPTP toxicity
-
Zuddas A., Fascetti F., Corsini G.U., Piccardi M.P. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but is not neurotoxic: A model of natural resistance to MPTP toxicity. Exp Neurol 1994, 127:54-61.
-
(1994)
Exp Neurol
, vol.127
, pp. 54-61
-
-
Zuddas, A.1
Fascetti, F.2
Corsini, G.U.3
Piccardi, M.P.4
|